HOME | SN-BRIEFS |
SYSTEM OVERVIEW |
EFFECTIVE MANAGEMENT |
PROGRESS PERFORMANCE |
PROBLEMS POSSIBILITIES |
STATE CAPITALS |
FLOW ACTIVITIES |
FLOW ACTORS |
PETER BURGESS |
SiteNav | SitNav (0) | SitNav (1) | SitNav (2) | SitNav (3) | SitNav (4) | SitNav (5) | SitNav (6) | SitNav (7) | SitNav (8) |
Date: 2024-03-29 Page is: DBtxt001.php txt00011227 |
Companies |
Burgess COMMENTARY |
Theranos' Last Defense Crumbles NBC News Special Anchor Maria Shriver and Theranos Founder and C.E.O. Elizabeth Holmes speak onstage at the Vanity Fair New Establishment Summit on October 6, 2015 in San Francisco. (Photo by Mike Windle/Getty Images for Vanity Fair) Last night the Wall Street Journal’s John Carreyrou published the latest in a series of amazing investigative pieces that have single-handedly dismantled the hype around Theranos, the blood testing company that claimed it would disrupt larger rivals like Laboratory Corporation of America and Quest Diagnostics DGX -0.74%. This article is important, because it is the moment when the Theranos’ last major defense of its image crumbled. Until now, Theranos and those close to the company could claim that its problems were limited to its laboratory in Newark, California, and that it had really done a fine job in Arizona, where most of its testing centers are. That claim lies demolished. The Journal reports that, in order to comply with regulators at the Centers for Medicare & Medicaid Services, Theranos has notified thousands of patients that test results it sent out in 2014 and 2015 were invalid. In the past, Theranos has vigorously contested the Journal’s reporting. This time, it acquiesced, saying in a statement that it has taken “comprehensive corrective measures to address the issues CMS raised in their observations.” That the problems extended to so many people, and to Arizona, which Theranos had made its beachhead into the diagnostics market, leads to a simple conclusion: Theranos just isn’t very good at running a diagnostic testing business. There will be other shoes to drop. Theranos’ chief executive and founder, Elizabeth Holmes, is trying to do what she needs to do to hold on to her company. CMS has threatened to ban her from the lab industry for two years, among other sanctions. |
Matthew Herper ... FORBES STAFF ... covers science and medicine, and believes this is biology's century.
MAY 19, 2016 @ 01:29 PM |
The text being discussed is available at http://www.forbes.com/sites/matthewherper/2016/05/19/theranos-last-defense-crumbles/ and |
SITE COUNT< Blog Counters Reset to zero January 20, 2015 | TrueValueMetrics (TVM) is an Open Source / Open Knowledge initiative. It has been funded by family and friends. TVM is a 'big idea' that has the potential to be a game changer. The goal is for it to remain an open access initiative. |
WE WANT TO MAINTAIN AN OPEN KNOWLEDGE MODEL | A MODEST DONATION WILL HELP MAKE THAT HAPPEN | |
The information on this website may only be used for socio-enviro-economic performance analysis, education and limited low profit purposes
Copyright © 2005-2021 Peter Burgess. All rights reserved. |